ARCHIVES

In a letter, ASCO reaffirms its views on oncology consolidation at FDA.

This article is from The Cancer Letter archive.

Vol. 30 No. 28 | July 9, 2004

Download PDF Visit The Full Archive

Related Articles

40 Years Later: Doctor and Patient Reflect on the Cure

October 24, 2014

BSA Approves Trial of Carbon Ion Therapy, Extends EDRN And Provocative Questions

July 4, 2014

Drugs and Targets: Akynzeo approved for chemotherapy-related nausea

October 10, 2014

NCI To Fund About 4,100 Grants; Increase Planned In Average Costs; Paylines Stable

November 20, 1998

New NCAB Appointees Include Some Old Hands; Korn Renamed Chairman

May 13, 1988

In Brief: Megastrol Acetate Still Under FDA Review; Mays Hired For NCI’s Technology Office

July 20, 1990